Skip to main content Skip to main navigation menu Skip to site footer
Hematology Meeting Reports

pISSN: 1970-7339

  • About the Journal
  • Editorial Board
  • Publication Ethics
  • Current Issue
  • Archives
  • Copyright & Licensing
  • Special Issues
    • Overview
  • Register
  • Login
  • Search
  • Contacts
  • News

Editor-in-Chief: Camillo Porta, Italy

Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma

    MG Bernengo, F Vanaclocha, M Duvic, T Kuzel, F Kerdel, L Pinter-Brown, A Bosly, C Okada, D Breneman, PL Zinzani, J Becker, L Hughey, M Ardaiz, J Zain, L Zhang
    2009-06-23
    https://doi.org/10.4081/hmr.v2i5.725
    0
    0
    0
    0
    Smart Citations
    0
    0
    0
    0
    Citing PublicationsSupportingMentioningContrasting
    View Citations

    See how this article has been cited at scite.ai

    scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

    205
    PDF: 217
  • Nodal aggressive non-Hodgkin’s lymphoma in the adult: a review article

    Maurizio Martelli, Paolo Corradini, Antonio Del Santo, Gianluca Gaidano, Alessandro M. Gianni, Pellegrino Musto, Stefano Pileri, Alessandro Rambaldi, Pier Luigi Zinzani, Sante Tura
    https://doi.org/10.4081/hmr.v1i12.355
    0
    0
    0
    0
    Smart Citations
    0
    0
    0
    0
    Citing PublicationsSupportingMentioningContrasting
    View Citations

    See how this article has been cited at scite.ai

    scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

    580
    PDF: 368
  • Innovative treatments: bortezomib

    PL Zinzani
    2009-06-11
    https://doi.org/10.4081/hmr.v3i1.545
    0
    0
    0
    0
    Smart Citations
    0
    0
    0
    0
    Citing PublicationsSupportingMentioningContrasting
    View Citations

    See how this article has been cited at scite.ai

    scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

    190
    PDF: 180
  • Gemcitabine: from solid tumor to hematology?

    PL Zinzani, M Tani, V Stefoni, E Marchi, M Fina, L Alinari
    2009-06-03
    https://doi.org/10.4081/hmr.v1i8.299
    0
    0
    0
    0
    Smart Citations
    0
    0
    0
    0
    Citing PublicationsSupportingMentioningContrasting
    View Citations

    See how this article has been cited at scite.ai

    scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

    175
    PDF: 444
  • Gemcitabine

    M Tani, L Alinari, A Broccoli, E Derenzini, M Fina, L Gandolfi, E Marchi, C Pellegrini, V Stefoni, F Venturini, PL Zinzani
    2009-06-11
    https://doi.org/10.4081/hmr.v3i1.542
    0
    0
    0
    0
    Smart Citations
    0
    0
    0
    0
    Citing PublicationsSupportingMentioningContrasting
    View Citations

    See how this article has been cited at scite.ai

    scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

    202
    PDF: 195
  • Chemotherapy in cutaneous T-cell lymphoma

    S Rupoli, MG Bernengo, R Alterini, M Cantonetti, PL Zinzani, N Pimpinelli
    2009-06-10
    https://doi.org/10.4081/hmr.v2i13.502
    0
    0
    0
    0
    Smart Citations
    0
    0
    0
    0
    Citing PublicationsSupportingMentioningContrasting
    View Citations

    See how this article has been cited at scite.ai

    scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

    207
    PDF: 415
  • Bortezomib

    PL Zinzani
    2009-06-10
    https://doi.org/10.4081/hmr.v2i13.496
    0
    0
    0
    0
    Smart Citations
    0
    0
    0
    0
    Citing PublicationsSupportingMentioningContrasting
    View Citations

    See how this article has been cited at scite.ai

    scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

    187
    PDF: 216
  • Conclusioni

    Pier Luigi Zinzani
    https://doi.org/10.4081/hmr.v2i1.780
    0
    0
    0
    0
    Smart Citations
    0
    0
    0
    0
    Citing PublicationsSupportingMentioningContrasting
    View Citations

    See how this article has been cited at scite.ai

    scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

    211
    PDF: 138
  • Improving the treatment paradigm for non-Hodgkin’s lymphoma with bortezomib

    PL Zinzani
    2009-06-08
    https://doi.org/10.4081/hmr.v2i7.409
    0
    0
    0
    0
    Smart Citations
    0
    0
    0
    0
    Citing PublicationsSupportingMentioningContrasting
    View Citations

    See how this article has been cited at scite.ai

    scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

    217
    PDF: 146
  • 90Y-ibritumumab tiuxetan (Zevalin)

    PL Zinzani
    2009-06-23
    https://doi.org/10.4081/hmr.v2i5.729
    0
    0
    0
    0
    Smart Citations
    0
    0
    0
    0
    Citing PublicationsSupportingMentioningContrasting
    View Citations

    See how this article has been cited at scite.ai

    scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

    247
    PDF: 376
  • Impact of radioimmumotherapy on aggressive non-Hodgkin’s lymphoma

    PL Zinzani
    2009-06-08
    https://doi.org/10.4081/hmr.v2i7.397
    0
    0
    0
    0
    Smart Citations
    0
    0
    0
    0
    Citing PublicationsSupportingMentioningContrasting
    View Citations

    See how this article has been cited at scite.ai

    scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

    193
    PDF: 156
1 - 11 of 11 items

Categories

    • AIEOP-Abstracts
    • Best abstracts
    • Oral Communications
    • Posters
Hematology Meeting Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

pISSN: 1970-7339

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2025    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy